CDH5 and chronic obstructive pulmonary disease: Immunofluorescence staining of VE‐cadherin in lung tissues demonstrated that the COPD + AS group had decreased expression of VE‐cadherin, while TXL–Ato combination treatment restored VE‐cadherin levels at cell–cell junctions (Figure 2d).